Metabotropic Glutamate 2/3 Receptor Agonists and Positive Allosteric Modulators of Metabotropic Glutamate Receptor 2 as Novel Agents for the Treatment of Schizophrenia-Reference-Cited by-同舟云学术

Metabotropic Glutamate 2/3 Receptor Agonists and Positive Allosteric Modulators of Metabotropic Glutamate Receptor 2 as Novel Agents for the Treatment of Schizophrenia

Published:2012-06-24 Issue: Volume: Page:143-185
ISSN:
Container-title:Targets and Emerging Therapies for Schizophrenia
language:
Short-container-title:

Author:

Marek Gerard J.,Kinon Bruce J.,McKinzie David L.,Schkeryantz Jeffrey M.,Monn James A.

Publisher

John Wiley & Sons, Inc.

Reference163 articles.

1. Effect of chlorpromazine and haloperidol on formation of 3-methoxytyramine and normetanephrine in mouse brain;Carlsson;Acta Pharmacol Toxicol (Copenh),1963

2. Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs;Creese;Science,1976

3. Antipsychotic drug doses and neuroleptic/dopamine receptors;Seeman;Nature,1976

4. The dissociative anesthetics, ketamine and phencyclidine, selectively reduce excitations of central mammalian neurons by N-methyl-aspartate;Anis;Br J Pharmacol,1983

5. The anticonvulsanat MK-801 is a potent N-methyl-D-aspartate antagonist;Wong;Proc Natl Acad Sci U S A,1986

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Input-specific regulation of glutamatergic synaptic transmission in the medial prefrontal cortex by mGlu 2 /mGlu 4 receptor heterodimers;Science Signaling;2021-04-06

2. mGluR2 positive allosteric modulators: an updated patent review (2013–2018);Expert Opinion on Therapeutic Patents;2019-07-03

3. Synthesis and Pharmacological Characterization of C4-Disubstituted Analogs of 1S,2S,5R,6S-2-Aminobicyclo[3.1.0]hexane-2,6-dicarboxylate: Identification of a Potent, Selective Metabotropic Glutamate Receptor Agonist and Determination of Agonist-Bound Human mGlu2 and mGlu3 Amino Terminal Domain Structures;Journal of Medicinal Chemistry;2015-02-05

4. Metabotropic Glutamate Receptor 2 Activators;Small Molecule Therapeutics for Schizophrenia;2014